Generic drugmaker Sandoz lowers sales outlook, lifts profit forecast
Swiss generic drugmaker Sandoz lowered full-year sales guidance to 5-6% but raised core earnings margin forecasts to 23%-23.5% by 2026, citing biosimilar supply constraints that impacted third-quarter
reuters · 2026-10-27 23:52 UTC